The Many Faces of MLKL, the Executor of Necroptosis
International Journal of Molecular Sciences · 14.06.2023 · 24 (12) · 10108
DOI: 10.3390/ijms241210108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.06.2023. Verfasst von Veronica Martinez-Osorio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931…. Hauptthemen laut MEDLINE: Apoptosis, Protein Kinases. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, German Research Foundation projects GA 1641/5-1, SFB1403, Special Issue Getting Molecules across Cellular Membranes: Transporters, Channels and Pores.
Abstract (Originalsprache)
Necroptosis is a recently discovered form of regulated cell death characterized by the disruption of plasma membrane integrity and the release of intracellular content. Mixed lineage kinase domain-like (MLKL) protein is the main player of this cell death pathway as it mediates the final step of plasma membrane permeabilization. Despite the significant progress in our knowledge of the necroptotic pathway and MLKL biology, the precise mechanism of how MLKL functions remain unclear. To understand in what way MLKL executes necroptosis, it is crucial to decipher how the molecular machinery of regulated cell death is activated in response to different stimuli or stressors. It is also indispensable to unveiling the structural elements of MLKL and the cellular players that are required for its regulation. In this review, we discuss the key steps that lead to MLKL activation, possible models that explain how it becomes the death executor in necroptosis, and its emerging alternative functions. We also summarize the current knowledge about the role of MLKL in human disease and provide an overview of existing strategies aimed at developing new inhibitors that target MLKL for necroptosis intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
Förderung
- DFG, German Research Foundation projects GA 1641/5-1
- SFB1403
- Special Issue Getting Molecules across Cellular Membranes: Transporters, Channels and Pores
Zitieren
APA
Martinez-Osorio, V., Abdelwahab, Y., & Ros, U. (2023). The Many Faces of MLKL, the Executor of Necroptosis. International Journal of Molecular Sciences, 24(12), 10108. https://doi.org/10.3390/ijms241210108
Vancouver
Martinez-Osorio V, Abdelwahab Y, Ros U. The Many Faces of MLKL, the Executor of Necroptosis. International Journal of Molecular Sciences. 2023;24(12):10108. doi:10.3390/ijms241210108
BibTeX
@article{MartinezOsorio2023,
author = {Martinez-Osorio, Veronica and Abdelwahab, Yasmin and Ros, Uris},
title = {The Many Faces of MLKL, the Executor of Necroptosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {10108},
doi = {10.3390/ijms241210108}
}
EUVIMED